Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102286000A reveals an enzymatic route for cefonicid. Achieve higher purity and reduced corrosion in antibiotic manufacturing with scalable solutions.
Patent CN103215238B details novel marine esterase PE8 for high-purity pharmaceutical intermediates. Enables cost reduction in API intermediate manufacturing with scalable enzymatic hydrolysis.
Patent CN113308443B reveals a mutant monooxygenase boosting azaphilone yield to 92.8%. Discover cost-effective, scalable biocatalytic manufacturing solutions.
Patent CN110343734B details a novel amidase method for L-glufosinate. Offers 100% theoretical yield and reduced environmental burden for agrochemical manufacturing.
Patent CN117003758A details enzymatic route for Sitagliptin. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110982800B reveals enzymatic aziridine synthesis offering green manufacturing and supply chain stability for pharmaceutical intermediates.
Patent CN113816836A details enzymatic route for liver drug intermediate. High purity, scalable, cost-effective supply chain solution.
Patent CN115572747B reveals a green enzymatic route for Topiroxostat, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN102787147B reveals enzymatic synthesis for L-dihydroorotic acid. Offers high purity, simplified separation, and scalable production for pharmaceutical intermediates.
Novel recombinant (R)-ω-transaminase mutant enables high-yield sitagliptin production with superior stereoselectivity and enzyme activity for pharmaceutical supply chains.
Patent CN105732663B reveals a novel activator boosting 6-APA yield. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Advanced enzymatic synthesis of levocarnitine via patent CN118879801B offers high yield and supply chain stability for global pharmaceutical manufacturers.
Novel enzymatic route for high-purity S-Allyl-L-Cysteine from GSAC. Reduces oxidation risks and improves yield for pharmaceutical applications.
Novel enzymatic method for high-purity L-tyrosine. Reduces impurities and simplifies supply chain for pharmaceutical intermediate manufacturing globally.
Patent CN112176011B reveals a papain-catalyzed route for valacyclovir hydrochloride. This green method eliminates palladium catalysts, offering significant cost reduction and supply chain stability for API manufacturers.
Patent CN115404226B discloses McSuSy enzyme for efficient glycosylation. Delivers high stability and yield for food additive intermediates manufacturing.
Patent CN109180691B reveals an enzymatic route for C3-aromatic pyrroloindole alkaloids. This method offers high optical purity and scalable production for neuroprotective drug development.
Patent CN116875576B reveals mutant LeuDH for L-phenylglycine. Offers high conversion, ee >99%, and scalable biocatalysis for pharmaceutical supply chains.
Novel BsLDH mutant enables efficient chiral amino acid synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN101659971A reveals a lipase-catalyzed route for stable hemiaminal synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain solutions.